Q Line Biotech Ltd vs Yuranus Infrastructure Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Q-Line Biotech Ltd is ₹ 529.55 as of 23 Oct 15:30 . The P/E Ratio of Q-Line Biotech Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Yuranus Infrastructure Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Q-Line Biotech Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Yuranus Infrastructure Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The Revenue of Q-Line Biotech Ltd is ₹ 90.03 crore as of Dec '25 .The Revenue of Yuranus Infrastructure Ltd is ₹ 0 crore as of Dec '25 . The EBITDA of Q-Line Biotech Ltd is ₹ 30.54 crore as of Dec '25 .The EBITDA of Yuranus Infrastructure Ltd is ₹ 0 crore as of Dec '25 . The Net Profit of Q-Line Biotech Ltd is ₹ 17.38 crore as of Dec '25 .The Net Profit of Yuranus Infrastructure Ltd is ₹ 0 crore as of Dec '25 . The Dividend Payout of Q-Line Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Yuranus Infrastructure Ltd changed from 7.29 % on March 2026 to 7.29 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Q-Line Biotech Ltd

Q-Line Biotech Limited was originally incorporated as 'POCT Services Private Limited' on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand.
Subsequently, the name of Company was changed to 'Q-Line Biotech Private Limited on July 23, 2021.
Further, Company was converted from a private company to public company and the name of Company was changed to 'Q-Line Biotech Limited', via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre. The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs.

About Yuranus Infrastructure Ltd

Yuranus Infrastructure Limited, formerly known as Pankhil Finlease Limited was incorporated on 22nd February 1994 as a Non Banking Financial Company (NBFC) with the object of carrying the business of Leasing, Hire Purchase, Financing, Trading, Merchant banking and Advisors to the Public Issue.
With the growth in the infrastructure and real estate field, the Company wanted to increase activities in the same sector and focus on the infrastructure and real estate sector as the main business activity.
And so, it changed the name to Yuranus Infrastructure Limited dated 17 April 2012 to carry out the new business purpose. The company came out with a public issue of 20,50,000 equity shares in March, 1996. The Company is in Manufacturing sector, it is engaged in Cotton Bales Manufacturing.
The Company is also involved in Trading and Export of Raw Cotton Bales and Cotton Seeds.

FAQs for the comparison of Q-Line Biotech Ltd and Yuranus Infrastructure Ltd

Which company has a larger market capitalization, Q-Line Biotech Ltd or Yuranus Infrastructure Ltd?

Market cap of Q-Line Biotech Ltd is 1,235 Cr while Market cap of Yuranus Infrastructure Ltd is 34 Cr

What are the key factors driving the stock performance of Q-Line Biotech Ltd and Yuranus Infrastructure Ltd?

The stock performance of Q-Line Biotech Ltd and Yuranus Infrastructure Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Q-Line Biotech Ltd and Yuranus Infrastructure Ltd?

As of October 25, 2026, the Q-Line Biotech Ltd stock price is INR ₹529.55. On the other hand, Yuranus Infrastructure Ltd stock price is INR ₹97.86.

How do dividend payouts of Q-Line Biotech Ltd and Yuranus Infrastructure Ltd compare?

To compare the dividend payouts of Q-Line Biotech Ltd and Yuranus Infrastructure Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.